PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 28 PubMed articles · model: gemma4:31b
Summary
Background
Active compounds
Clinical evidence
Fucus vesiculosus is often incorporated into dietary supplements to improve weight loss in overweight adults [PMID:30332899].
Safety & adverse effects
Pregnancy & lactation
Drug interactions
Evidence summary
PubMed sources
- 1.PMID: 30000910 (2006) — Kelp forests. · Current biology : CB
- 2.PMID: 30332899 (2020) — Safety evidence on the administration of Fucus vesiculosus L. (bladderwrack) extract and lamotrigine: data from pharmacokinetic studies in the rat. · Drug and chemical toxicology
- 3.PMID: 21547758 (2011) — Surface-associated fucoxanthin mediates settlement of bacterial epiphytes on the rockweed Fucus vesiculosus. · Biofouling
- 4.PMID: 28869777 (2017) — Genetic variation of a foundation rockweed species affects associated communities. · Ecology
- 5.PMID: 29669995 (2018) — Pharmacokinetic and Tissue Distribution of Fucoidan from Fucus vesiculosus after Oral Administration to Rats.